Kensington, MD, United States of America

Theresa J Goletz

This inventor holds 3 USPTO granted patents. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, The United States of America as Represented by the Department of Health. Active years: 1999-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Theresa J Goletz. Retrieved from https://idiyas.com/inventor/theresa-j-goletz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 66.7

Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 62(Granted Patents)


Company Filing History:


Years Active: 1999-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Theresa J Goletz

Introduction

Theresa J Goletz is a notable inventor based in Kensington, MD (US). She has made significant contributions to the field of immunology, particularly in the development of vaccines. With a total of 3 patents to her name, her work has the potential to impact public health positively.

Latest Patents

One of her latest patents focuses on targeting antigens to the MHC class I processing pathway using an anthrax toxin fusion protein. This invention provides a vaccine designed to induce an immune response in mammals to a specific antigen. The vaccine comprises a unit dose of a binary toxin protective antigen and the antigen, which is bound to a binary toxin protective antigen binding protein. In another embodiment, the vaccine includes an anthrax protective antigen and the antigen bound to an anthrax protective antigen binding protein. This patent also outlines methods for immunizing mammals against an antigen and inducing antigen-presenting mammalian cells to present specific antigens via the MHC class I processing pathway.

Another patent by Goletz also addresses the same theme of targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein. This invention provides a vaccine that includes a binary, cytotoxic T lymphocyte vaccine comprising an anthrax protective antigen and a full-length protein antigen bound to a nontoxic anthrax protective antigen binding protein. This patent further elaborates on methods for immunization and antigen presentation.

Career Highlights

Throughout her career, Theresa J Goletz has worked with esteemed organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and the United States of America as represented by the Department of Health. Her work in these institutions has allowed her to contribute significantly to public health initiatives.

Collaborations

Theresa has collaborated with notable professionals in her field, including Jay A Berzofsky and Kurt Klimpel. These collaborations have likely enriched her research and development efforts.

Conclusion

Theresa J Goletz is a pioneering inventor whose work in vaccine development has the potential to advance immunological research and public health. Her innovative patents reflect her commitment to improving health outcomes through scientific discovery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…